GO:0030544 Hsp70 protein binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030544 (Hsp70 protein binding) is a molecular function describing the selective binding of a protein to an Hsp70 family chaperone, a ~70 kDa heat shock protein.
• Hsp70 binding is driven by J-domain proteins (HSP40s) that deliver client polypeptides and stimulate ATP hydrolysis, converting Hsp70 into a high-affinity state.
• The interaction is multivalent and regulated by nucleotide state, co-chaperones, and client conformational features, allowing selective promiscuity across many substrates.
• Hsp70 protein binding is central to proteostasis, protein folding, disaggregation, and stress survival, and its dysfunction is linked to cancer and neurodegeneration.
• Key experimental approaches include co-immunoprecipitation, crosslinking mass spectrometry, fluorescence polarization, and CRISPR-based perturbation of Hsp70 network genes.
• EDITGENE provides knockout, point-mutation, knock-in, overexpression cell models and CRISPR library screening to dissect Hsp70 protein binding in disease contexts.
Description
GO:0030544, Hsp70 protein binding, is a molecular function term that captures the physical interaction between a protein and a member of the Hsp70 (heat shock protein 70 kDa) family. Hsp70 chaperones are ATP-dependent machines that bind exposed hydrophobic segments of client proteins, preventing aggregation and facilitating folding, translocation, and degradation. The binding event itself is not a passive association; it is a regulated, nucleotide-controlled step that determines substrate fate and is orchestrated by J-domain proteins and nucleotide exchange factors. For researchers, GO:0030544 is therefore a functional annotation that connects a candidate protein to the entire Hsp70 chaperone network and to proteostasis-related phenotypes. Because Hsp70 binding is implicated in cancer cell survival, neurodegeneration, and stress responses, it is a high-value target for mechanistic studies and therapeutic development. Understanding which proteins bind Hsp70, how binding is regulated, and what consequences it has requires precise genetic and biochemical tools, which is why CRISPR-based models are increasingly used in this field.
Hsp70 protein binding At A Glance
| GO ID | GO:0030544 |
|---|---|
| GO term | Hsp70 protein binding |
| Ontology | molecular_function |
| Synonym | none listed in QuickGO |
| Major function | Binding to an Hsp70 family chaperone, typically via client or co-chaperone interaction |
| Definition source | QuickGO: Binding to a Hsp70 protein, heat shock proteins around 70kDa in size |
| Related chaperone family | Hsp70 (HSPA) proteins, ~70 kDa ATP-dependent chaperones |
| Key co-chaperones | J-domain proteins (HSP40s), nucleotide exchange factors |
| Biological context | Protein folding, proteostasis, stress response, disaggregation |
What Is GO:0030544?
In plain terms, GO:0030544 means a protein physically binds to an Hsp70 chaperone. The QuickGO definition states: Binding to a Hsp70 protein, heat shock proteins around 70kDa in size. This is a molecular_function annotation, so it describes an activity rather than a location or a whole pathway. The interaction is typically mediated by the substrate-binding domain of Hsp70 and can involve unfolded or partially folded client proteins, co-chaperones, or regulatory partners. The term does not specify which Hsp70 family member is bound, nor does it require a particular downstream outcome; it simply records the binding event.
Why Is Hsp70 protein binding Important in Cell Biology?
Hsp70 protein binding is important because it sits at the decision point of protein quality control: whether a client is folded, refolded, translocated, or degraded. The Hsp70 chaperone network is one of the most conserved and abundant systems in cells, and its binding interactions influence nearly every branch of proteostasis. Because Hsp70 binding is ATP-dependent and tightly regulated by co-chaperones, it is also a druggable node, with Hsp70 complexes actively pursued as therapeutic targets in cancer and other diseases. For researchers, annotating a protein with GO:0030544 immediately places it in a network with known genetic and pharmacological handles, enabling hypothesis-driven experiments.
• Hsp70 protein binding is a core step in ATP-dependent protein folding and refolding.
• It enables selective recognition of unfolded or partially folded client proteins, preventing aggregation.
• J-domain proteins (HSP40s) determine the functional specificity of Hsp70 binding events.
• Multivalent interactions regulate eukaryotic Hsp70 complex assembly and stability.
• Hsp70 binding is linked to cancer cell survival and resistance to proteotoxic stress.
• Neurodegenerative diseases often involve disrupted Hsp70-client interactions and aggregation.
• Hsp70 complexes are considered drug targets, making binding assays translationally relevant.
• The interaction is conserved from bacteria to humans, supporting cross-species mechanistic studies.
• Sulfatide and other cofactors can modulate Hsp70 clustering and client binding.
• CRISPR perturbation of Hsp70 network genes enables causal testing of binding-dependent phenotypes.
Molecular Mechanism of Hsp70 protein binding
Client recognition and delivery by J-domain proteins
In simple terms: Helper proteins grab unfolded clients and hand them to Hsp70.
Hsp70 does not act alone; J-domain proteins (HSP40s) bind unfolded or partially folded client proteins and deliver them to Hsp70, simultaneously stimulating the ATPase activity of Hsp70. This delivery step is a major determinant of functional specificity, because different J-domain proteins target different clients and cellular compartments. The interaction between the J-domain and Hsp70 is itself a form of Hsp70 protein binding that couples client recognition to the chaperone cycle.
ATP-dependent conformational cycle and high-affinity binding
In simple terms: Hsp70 changes shape depending on whether ATP or ADP is bound, and this controls how tightly it holds clients.
Hsp70 operates through an allosteric cycle in which ATP binding opens the substrate-binding domain and accelerates client exchange, while ATP hydrolysis, stimulated by J-domain proteins, locks the substrate-binding domain into a high-affinity state that traps the client. Nucleotide exchange factors promote ADP release and reset the cycle. This cycle ensures that Hsp70 protein binding is transient and regulated rather than constitutive, and it allows the chaperone to discriminate between substrates based on conformational state.
Selective promiscuity and multivalent interactions
In simple terms: Hsp70 can bind many different proteins, but it still prefers certain features and can form multi-contact complexes.
Hsp70 is often described as promiscuous because it binds a wide range of client proteins, yet biochemical studies show selective promiscuity: it recognizes distinct features of unfolded proteins and can discriminate among clients. In eukaryotic cells, Hsp70 complexes are stabilized by multivalent protein-protein interactions, meaning several weak contacts combine to produce specific and regulated binding. Human Hsp70 substrate-binding domains can also recognize distinct client proteins, further supporting selectivity within the network.
Cofactor and lipid modulation of Hsp70 binding
In simple terms: Other molecules, including lipids, can change how Hsp70 clusters and binds clients.
Hsp70 binding is modulated by co-chaperones and by non-protein factors. For example, sulfatide interacts with Hsp70, promotes Hsp70 clustering, and stabilizes binding to unfolded protein, illustrating that lipid environments can influence chaperone function. This adds another layer of regulation beyond the canonical ATPase cycle and J-domain protein delivery.
Regulation of the Hsp70 network
In simple terms: Cells tune Hsp70 binding by controlling chaperone levels, co-chaperone availability, and stress signals.
The Hsp70 chaperone network is regulated at multiple levels, including expression of Hsp70 genes under stress, availability of J-domain proteins and nucleotide exchange factors, and post-translational modifications. Because Hsp70 protein binding is central to proteostasis, its regulation is integrated with cellular stress responses and protein quality control pathways. Dysregulation of this network can shift the balance between folding and aggregation, with disease consequences.
Key Genes Involved in GO:0030544 Hsp70 protein binding
The following genes and proteins are central to Hsp70 protein binding, either as Hsp70 family members, co-chaperones, or client/regulatory factors.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HSPA1A | Cytosolic Hsp70 chaperone; binds unfolded clients | Core Hsp70 protein binding; stress protection |
| HSPA1B | Cytosolic Hsp70 paralog | Redundancy and isoform-specific binding studies |
| HSPA8 | Constitutively expressed Hsc70; chaperone | Housekeeping proteostasis and trafficking |
| HSPA5 | ER Hsp70 (BiP); ER folding | ER stress and secretory pathway |
| HSPA9 | Mitochondrial Hsp70 (mortalin) | Mitochondrial proteostasis and cancer |
| DNAJA1 | J-domain protein; stimulates Hsp70 ATPase | Client delivery and specificity |
| DNAJB1 | J-domain protein; co-chaperone | Hsp70 binding regulation |
| DNAJC proteins | J-domain protein family | Functional diversity of Hsp70 binding |
| HSPH1 | Nucleotide exchange factor | Regulates Hsp70 cycle and substrate release |
| BAG1 | Nucleotide exchange factor | Modulates Hsp70 binding and degradation |
| BAG3 | Co-chaperone; chaperone-assisted selective autophagy | Hsp70 complex in proteostasis |
| STIP1 | Co-chaperone (HOP); bridges Hsp70 and Hsp90 | Multivalent Hsp70 complex assembly |
| CHIP (STUB1) | E3 ubiquitin ligase; interacts with Hsp70 | Links Hsp70 binding to degradation |
| HSF1 | Transcription factor for heat shock genes | Regulates Hsp70 expression |
| TP53 | Tumor suppressor; client of Hsp70 network | Cancer-related Hsp70 binding |
| CFTR | Chloride channel; folding client | Misfolding disease and Hsp70 interaction |
| SNCA | Alpha-synuclein; aggregation-prone client | Neurodegeneration and Hsp70 binding |
| MAPT | Tau; microtubule-associated client | Neurodegeneration and chaperone interactions |
How Is Hsp70 protein binding Regulated?
Hsp70 protein binding is regulated by the nucleotide state of Hsp70, by J-domain proteins that stimulate ATP hydrolysis and deliver clients, and by nucleotide exchange factors that promote substrate release. Multivalent protein-protein interactions within eukaryotic Hsp70 complexes further tune binding specificity and stability. Expression of Hsp70 genes is controlled by stress-responsive transcription factors such as HSF1, and cofactor availability can shift the balance between folding and degradation. In addition, non-protein factors such as sulfatide can modulate Hsp70 clustering and client binding.
Hsp70 protein binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HSPA1A | Cancer, stress resistance | Knockout and overexpression cell lines |
| HSPA9 | Cancer, mitochondrial dysfunction | Point-mutation and knockout models |
| STUB1 (CHIP) | Neurodegeneration, protein quality control | Knock-in and knockout models |
| SNCA | Parkinson's disease, aggregation | Knock-in and overexpression models |
| CFTR | Cystic fibrosis, misfolding | Knock-in and point-mutation models |
Cancer and Hsp70 protein binding
Hsp70 chaperones are often overexpressed in cancer cells, where they support survival under proteotoxic stress and stabilize oncogenic clients. Hsp70 protein complexes have therefore been pursued as drug targets, with efforts to inhibit Hsp70-client binding or disrupt co-chaperone interactions. Because Hsp70 binding influences apoptosis, metastasis, and therapy resistance, it is a high-priority area for mechanistic and translational research.
Neurodegeneration and protein aggregation
Many neurodegenerative diseases involve aggregation of misfolded proteins, and Hsp70 binding is a key line of defense against aggregation. Hsp70 and its co-chaperones can bind aggregation-prone proteins and modulate their toxicity, although the outcomes depend on the specific client and cellular context. Disruption of Hsp70 protein binding can therefore contribute to disease progression, making this interaction a potential therapeutic node.
Proteostasis and stress-related disorders
Hsp70 protein binding is central to protein homeostasis, and its dysfunction is linked to a broad range of stress-related and age-related disorders. Because the Hsp70 network integrates folding, trafficking, and degradation, perturbations in binding can have pleiotropic effects. This makes Hsp70 binding relevant not only to rare folding diseases but also to common conditions where proteostasis declines.
From Hsp70 protein binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of Hsp70 binding alter client folding? | Knockout of Hsp70 or co-chaperone genes |
| Does a specific Hsp70 mutation change substrate affinity? | Point-mutation knock-in of HSPA1A |
| Can a disease-linked client mutation disrupt Hsp70 binding? | Knock-in of client point mutation |
| Where does Hsp70 bind clients in cells? | Tagged knock-in for imaging and proteomics |
| Does Hsp70 overexpression protect against stress? | Overexpression cell models |
| Which genes modify Hsp70-dependent phenotypes? | CRISPR library screening |
How to Study the Hsp70 protein binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-immunoprecipitation | Protein-protein interactions | Identifying Hsp70 clients and co-chaperones |
| Crosslinking mass spectrometry | Binding interfaces and multivalency | Mapping Hsp70 complex architecture |
| Fluorescence polarization | Binding affinity and kinetics | Quantifying Hsp70-client interactions |
| Surface plasmon resonance | Real-time binding kinetics | Comparing mutant Hsp70 binding |
| Fluorescence microscopy | Cellular localization and clustering | Visualizing Hsp70 binding in cells |
| CRISPR knockout | Loss-of-function phenotypes | Testing Hsp70 gene requirement |
| CRISPR library screening | Genetic modifiers | Discovering Hsp70 pathway regulators |
Biochemical binding assays
Direct measurement of Hsp70 protein binding can be performed using purified proteins and techniques such as fluorescence polarization, surface plasmon resonance, or isothermal titration calorimetry. These assays reveal affinity, kinetics, and the effect of nucleotide state or co-chaperones. They are essential for validating interactions suggested by genetic or proteomic screens.
Proteomics and interactomics
Co-immunoprecipitation coupled to mass spectrometry can identify proteins that bind Hsp70 in cells, providing a global view of the Hsp70 interactome. Crosslinking mass spectrometry can map binding interfaces and multivalent contacts within Hsp70 complexes. These approaches are powerful for discovering client proteins and co-chaperones.
Imaging and cellular assays
Fluorescence microscopy of tagged Hsp70 and clients can visualize co-localization, clustering, and dynamics of Hsp70 protein binding in live cells. Such assays can test how mutations or drugs affect binding and aggregation. They complement biochemical data by providing spatial and temporal context.
Genetic perturbation and screening
CRISPR knockout, point-mutation, and overexpression models allow causal testing of Hsp70 binding in cells. CRISPR library screening can identify modifiers of Hsp70-dependent phenotypes, linking binding to pathways and disease. These genetic tools are increasingly combined with proteomics and imaging for integrated analysis.
How CRISPR Can Be Used to Study GO:0030544 Hsp70 protein binding
Knockout
CRISPR knockout of Hsp70 family genes or co-chaperones can reveal which components are required for client folding, stress survival, and disease phenotypes. Knockout models are useful for testing whether a specific Hsp70 protein binding event is essential or redundant. They also provide a clean background for rescue experiments with wild-type or mutant Hsp70.
Point Mutation
Point-mutation knock-in can dissect the contribution of specific residues in Hsp70 or its clients to binding affinity and function. For example, mutations in the substrate-binding domain can alter client recognition without abolishing chaperone expression. Such models are valuable for linking structural features to cellular phenotypes.
Knock-in
Knock-in of tags, reporters, or disease-associated alleles allows tracking of Hsp70 protein binding in native contexts. Tagged knock-in can enable imaging and proteomic pull-down of endogenous Hsp70 complexes. Disease-linked knock-in models can test whether a mutation disrupts Hsp70 binding and contributes to pathology.
Overexpression
Overexpression of Hsp70 or its co-chaperones can test whether increased binding capacity protects against stress or aggregation. Overexpression models are also used to study gain-of-function effects in cancer and neurodegeneration. They complement knockout studies by revealing sufficiency rather than requirement.
How EDITGENE Supports Hsp70 protein binding Research
Researchers studying Hsp70 protein binding-related genes often need to determine whether a candidate gene is causally involved in chaperone-client interactions, stress responses, or disease phenotypes. EDITGENE provides publication-ready CRISPR cell models and screening services to test these hypotheses with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for Hsp70 protein binding research.
Frequently Asked Questions About Hsp70 protein binding
What is GO:0030544 Hsp70 protein binding?
GO:0030544 is a molecular function term describing the binding of a protein to an Hsp70 chaperone, a heat shock protein around 70 kDa in size.
What genes are involved in Hsp70 protein binding?
Key genes include HSPA1A, HSPA1B, HSPA8, HSPA5, HSPA9, DNAJA1, DNAJB1, HSPH1, BAG1, BAG3, STIP1, and STUB1, among others.
How does Hsp70 bind client proteins?
J-domain proteins deliver unfolded clients to Hsp70 and stimulate ATP hydrolysis, which locks the substrate-binding domain into a high-affinity state.
Why is Hsp70 protein binding important in cancer?
Hsp70 binding supports cancer cell survival under proteotoxic stress and stabilizes oncogenic clients, making Hsp70 complexes drug targets.
Is Hsp70 protein binding involved in neurodegeneration?
Yes, Hsp70 binding modulates aggregation-prone proteins linked to neurodegeneration, and its dysfunction can contribute to disease.
What methods study Hsp70 protein binding?
Common methods include co-immunoprecipitation, crosslinking mass spectrometry, fluorescence polarization, surface plasmon resonance, and CRISPR perturbation.
Can CRISPR be used to study Hsp70 protein binding?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of Hsp70 binding in cells.
What is the difference between Hsp70 and Hsc70?
Hsp70 usually refers to stress-inducible family members such as HSPA1A, while Hsc70 (HSPA8) is constitutively expressed; both can bind clients.
How is Hsp70 protein binding regulated?
It is regulated by nucleotide state, J-domain proteins, nucleotide exchange factors, multivalent interactions, and factors such as sulfatide.
What cell models are available for Hsp70 research?
EDITGENE offers knockout, point-mutation, knock-in, tagged knock-in, overexpression cell models, and CRISPR library screening for Hsp70 network studies.
Conclusion
GO:0030544 Hsp70 protein binding is a fundamental molecular function that connects a protein to the conserved Hsp70 chaperone network, influencing folding, proteostasis, and disease. Its regulation by nucleotide state, J-domain proteins, and multivalent interactions makes it a rich area for mechanistic study and therapeutic targeting. CRISPR-based models and biochemical assays provide the tools needed to dissect these interactions with precision.
References
- 1. Kampinga HH et al.. 2010. The HSP70 chaperone machinery: J proteins as drivers of functional specificity.. Nat Rev Mol Cell Biol 11(8):579-92 PMID: 20651708
- 2. Wentink A et al.. 2026. Mechanisms and regulation of the Hsp70 chaperone network.. Nat Rev Mol Cell Biol 27(2):110-128 PMID: 41145833
- 3. Harada Y et al.. 2015. Sulfatide-Hsp70 interaction promotes Hsp70 clustering and stabilizes binding to unfolded protein.. Biomolecules 5(2):958-73 PMID: 25989600
- 4. Johnson OT et al.. 2022. Multivalent protein-protein interactions are pivotal regulators of eukaryotic Hsp70 complexes.. Cell Stress Chaperones 27(4):397-415 PMID: 35670950
- 5. Clerico EM et al.. 2021. Selective promiscuity in the binding of E. coli Hsp70 to an unfolded protein.. Proc Natl Acad Sci U S A 118(41) PMID: 34625496
- 6. Fernández-Fernández MR et al.. 2018. Hsp70 chaperone: a master player in protein homeostasis.. F1000Res 7 PMID: 30338057
- 7. Ambrose AJ et al.. 2024. Human Hsp70 Substrate-Binding Domains Recognize Distinct Client Proteins.. Biochemistry 63(3):251-263 PMID: 38243804
- 8. Assimon VA et al.. 2013. Hsp70 protein complexes as drug targets.. Curr Pharm Des 19(3):404-17 PMID: 22920901
